Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians

Journal of Community Genetics

Volumn 1, Issue 3, 2010, Pages 139-148

  Bhanushali, Aparna A ^a   Das, Bibhu R ^a  

^a Research and Development   (India)

Author keywords

Apolipoprotein A5; Apolipoprotein C3; Coronary artery disease; Haplotypes; India; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79952361883     PISSN: 1868310X     EISSN: 18686001     Source Type: Journal    
DOI: 10.1007/s12687-010-0025-x     Document Type: Article

References (39)

1. Assmann G, Schulte H, von Eckardstein A (1996) Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 7(14):1179-1184 (Pubitemid 26186958)
2. Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11(1):2-14
3. Chandak GR, Ward KJ, Yajnik CS et al (2006) Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune. India compared to Europeans. BMC Med Genet 7:33
4. Chhabra S, Narang R, Lakshmy R et al (2004) Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD. Mol Cell Biochem 259(1-2):59-66 (Pubitemid 38519216)
5. Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N (2006) Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol 106:152-156 (Pubitemid 41728931)
6. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL (1993) An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci USA 90(10):4562-4566 (Pubitemid 23148945)
7. Grallert H, Sedlmeier EM, Huth C et al (2007) APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res 48(12):2614-2621 (Pubitemid 350272846)
8. Groenendijk MR, Cantor M, deBruin TW, Dallinga-Thie GM (2001) The apoAI-CIII-AIV gene cluster. Atherosclerosis 157:1-11 (Pubitemid 32539348)
9. Hodoglugil U, Tanyolac S, Williamson DW, Huang Y, Mahley RW (2006) Apolipoprotein A-V: A potential modulator of plasma triglyceride levels in Turks. J Lipid Res 47:144-153 (Pubitemid 43107458)
10. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219 (Pubitemid 26266496)
11. Hsu LA, Ko YL, Chang CJ et al (2006) Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 185:143-149
12. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL (1990) Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249:790-793
13. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW (2003) A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 12:2533-2539
14. Ko YL, Ko YS, Wu SM et al (1997) Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet 100:327-333
15. Lai CQ, Tai ES, Tan CE et al (2003) The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 44:2365-2373 (Pubitemid 38082495)
16. Lai CQ, Demissie S, Cupples A et al (2004) Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the framingham heart study. J Lipid Res 45:2096-2105 (Pubitemid 40990904)
17. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J (1994) Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 269:23610-23616 (Pubitemid 24293564)
18. Martin S, Nicaud V, Humphries SE, Talmud PJ (2003) Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 1637:217-225 (Pubitemid 36407772)
19. Martinelli N, Trabetti E, Bassi A et al (2007) The -1131T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: An angiographic study. Atherosclerosis 191(2):409-417 (Pubitemid 46400704)
20. Mc Keigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South-Asians overseas: A review. J Clin Epidemiol 41:597-609 (Pubitemid 19190639)
21. Paul-Hayase H, Rosseneu M, Robinson D, van Bervliet JP, Deslypere JP, Humphries SE (1992) Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 88:439-446
22. Pennacchio LA, Rubin EM (2003) Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol 23:529-534 (Pubitemid 36438063)
23. Pennacchio LA, Olivier M, Hubacek JA et al (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169-173 (Pubitemid 32952971)
24. Pennacchio LA, Olivier M, Hubacek J, Krauss RM, Rubin EM, Cohen JC (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031-3038 (Pubitemid 35414816)
25. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE (1983) DNA polymorphism adjacent to human apolipoprotein A-1 gene: Relation to hypertriglyceridemia. Lancet 1:444-446 (Pubitemid 13137377)
26. Ruiz-Narváez EA, Yang Y, Nakanishi Y, Kirchdorfer J, Campos H (2005) APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res 46:2605-2613 (Pubitemid 43107472)
27. Russo GT, Meigs JB, Cupples A et al (2001) Association of the Sst-I polymorphism at the APOC 3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: The Framingham offspring study. Atherosclerosis 158:173-181 (Pubitemid 32735482)
28. Sarwar N, Danesh J, Eiriksdottir G et al (2007) Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115(4):450-458 (Pubitemid 46184196)
29. Shanker J, Perumal G, Rao VS et al (2008) Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis 7:33
30. Szalai C, Keszei M, Duba J et al (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with increased susceptibility for coronary artery disease. Atherosclerosis 173:109-114 (Pubitemid 38224202)
31. Talmud PJ, Hawe E, Martin S et al (2002) Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11(24):3039-3046 (Pubitemid 35414817)
32. Talmud PJ, Martin S, Taskinen MR et al (2004) APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: Results from the LOCAT study. J Lipid Res 45:750-756 (Pubitemid 38405682)
33. Tang YP, Sun D, Guo A, Ji Ferro Y, Chen Q, Fan L (2006) A genetic variant c.553G>T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis 185:433-437
34. Vaessen SFC, Schaap FG, Kuivenhoven JA et al (2006) Apolipoprotein A-V, triglycerides and risk of coronary artery disease: The prospective EPIC-Norfolk Population Study. J Lipid Res 47:2064-2070 (Pubitemid 44401995)
35. Waterworth DM, Ribalta J, Nicaud V, Dallongville J, Humphries SE, Talmud P (1999) ApoCIIIgene variants modulate post-prandial response to both glucose and fat tolerance tests. Circulation 99:1872-1877 (Pubitemid 29181417)
36. Waterworth DM, Talmud PJ, Bujac SR, Fisher RM, Miller GJ, Humphries SE (2000) Contribution of Apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men. Arterioscler Thromb Vasc Biol 20:2663-2669
37. Wong WR, Hawe E, Li LK et al (2003) Apolipoprotein AIV gene variant is associated with increased risk of coronary heart disease and lower ApoAIV plasma concentrations. Circ Res 92:969-972
38. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J (1995) An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 95:371-375
39. Ordovas JM (2007) Gender, a significant factor in the cross talk between genes, environment, and health. Gend Med 4(Suppl B):111-121